How socioeconomic factors affect outcomes in this deadly cancer
Black women diagnosed with hormone receptor–positive (HR+) breast cancer experience significantly worse outcomes than white women.
Онкология
Рак молочной железы
677 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
Virtual Tumor Models Reveal Promising Treatment Strategies for Triple-Negative Breast Cancer
Virtual Tumor Models Reveal Promising Treatment Strategies for Triple-Negative Breast Cancer Inside Precision Medicine
Онкология
Maria Hafez: Bridging Gaps in Breast Cancer Care and Access Through Research at ESMO26
Maria Hafez: Bridging Gaps in Breast Cancer Care and Access Through Research at ESMO26 Oncodaily
Онкология
Targeted drug significantly delays advanced breast cancer progression but increases toxicity, phase III trial reports
In a global phase 1 trial, trastuzumab rezetecan showed promising signs of fighting ERBB2-low metastatic breast cancer in patients who had already undergone extensive treatment. Also known as HER2-low breast cancer, this subtype is characterized by low levels of HER2, a growth factor protein that can still be targeted…
Онкология
ESMO26: Breast cancer treatment landscape continues to be redefined
ESMO26: Breast cancer treatment landscape continues to be redefined Clinical Trials Arena
Онкология
ESMO26: Breast cancer treatment landscape continues to be redefined
ESMO26: Breast cancer treatment landscape continues to be redefined Yahoo Finance
Онкология
Exploring the potential of immunotherapy in early-stage triple-negative breast cancer
Triple-negative breast cancers, which are more frequently diagnosed in younger women, are a subtype of breast tumor characterized by the absence of hormone receptors and HER2 overexpression. As a result, they do not respond to hormone therapy or HER2-targeted treatments. Their prognosis is generally less favorable…
Онкология
Tomosynthesis detects breast cancer more frequently during screening
With around 75,000 new cases per year, breast cancer is by far the most common cancer among women in Germany. Using digital breast tomosynthesis in the breast cancer screening program could prevent around a quarter of invasive interval cancers that occur within two years after a digital mammogram.
🎗️
Онкология
Less Can Be More in Breast Cancer Treatment, Precision Oncology Editors Argue
Less Can Be More in Breast Cancer Treatment, Precision Oncology Editors Argue Bioengineer.org
Онкология
Laura Esserman Wins 2026 AIM-HI Beacon Award for Breast Cancer Leadership
Laura Esserman Wins 2026 AIM-HI Beacon Award for Breast Cancer Leadership Bioengineer.org
Онкология
Breast Cancer Index influences extended endocrine therapy choice
Results from Breast Cancer Index testing prompted more than 40% of physicians to change extended endocrine therapy decisions for women with early-stage, hormone receptor-positive breast cancer. An analysis of nearly 3,000 patients found the number of physicians who reported high confidence in their decision-making…
Онкология
Месяц розовой ленты: что нужно знать о маммографии и лечении рака в Украине бесплатно - РБК-Україна
Месяц розовой ленты: что нужно знать о маммографии и лечении рака в Украине бесплатно РБК-Україна
Онкология
Datroway Shows Encouraging Results for Triple-Negative Breast Cancer That Has Spread to the Brain
Datroway Shows Encouraging Results for Triple-Negative Breast Cancer That Has Spread to the Brain news.cancerconnect.com
Онкология
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study BioPharma Dive